Categories: Covid-19U. S. News

US States Face Steep Decline in J&J COVID Vaccine Amid Production Problems

Johnson & Johnson is scaling back shipments of its single-dose COVID-19 vaccine by 86% next week as it grapples with manufacturing issues at a major plant in Baltimore.

The government has allocated only 700,000 J&J shots to states next week, down from 4.9 million the week prior, according to data from the Centers for Disease Control and Prevention.

MDMH Staff

Recent Posts

A night of celebration in Lauderdale Lakes ends in tragedy as gunfire erupts, leaving the community searching for answers after a fatal shooting

Lauderdale Lakes, Florida – What started as a night of celebration ended in chaos and…

6 months ago